2 unknown, 1 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors Shengxuening Tablet, Ferrous succinate - Hematological Malignancy, Cancer-Related Anemia | Phase 3 | Unknown | Zhongnan Hospital | 168 | 2023-02-07 | 2023-08-25 |
| Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours CAR-T cell therapy - Hematological Malignancy | Phase 2 / Phase 3 | Unknown | Shanxi Bethune Hospital | 30 | 2020-06-15 | 2024-02-02 |
| Pharmacologic Optimization of Voriconazole voriconazole, voriconazole (dosing according to the SPC) - Invasive Fungal Infection, Hematological Malignancy | Phase 3 | Completed | Jan-Willem C Alffenaar | 189 | 2009-04-01 | 2017-01-12 |
Hematologic Neoplasms (3) · Invasive Fungal Infections (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Bacterial Infections and Mycoses (1) · Infections (1) · Mycoses (1)
Immunotherapy, Adoptive (1) · Voriconazole (1) · ferrous succinate (1) · shengxuening (1)
Jan-Willem C Alffenaar (1) · Shanxi Bethune Hospital (1) · Zhongnan Hospital (1)
China (2) · Netherlands (1)
J GW Kosterink, PharmD, PhD (1) · J WC Alffenaar, PharmD PhD (1) · Xiaomin Zhang (1)